Global Allergy Immunotherapy Market Growth 2023-2029

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

LPI (LP Information)' newest research report, the “Allergy Immunotherapy Industry Forecast” looks at past sales and reviews total world Allergy Immunotherapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Allergy Immunotherapy sales for 2023 through 2029. With Allergy Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Allergy Immunotherapy industry.

This Insight Report provides a comprehensive analysis of the global Allergy Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Allergy Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Allergy Immunotherapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Allergy Immunotherapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Allergy Immunotherapy.

The global Allergy Immunotherapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.

This report presents a comprehensive overview, market shares, and growth opportunities of Allergy Immunotherapy market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Subcutaneous Immunotherapy
    Sublingual Immunotherapy

Segmentation by application
    Allergic Rhinitis
    Allergic Asthma
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    ALK-Abello
    Stallergenes Greer
    Merck
    Allergy Therapeutics
    HAL
    Holister Stier
    Leti

Key Questions Addressed in this Report
What is the 10-year outlook for the global Allergy Immunotherapy market?
What factors are driving Allergy Immunotherapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Allergy Immunotherapy market opportunities vary by end market size?
How does Allergy Immunotherapy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Allergy Immunotherapy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Allergy Immunotherapy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Subcutaneous Immunotherapy
    Table 4. Major Players of Sublingual Immunotherapy
    Table 5. Global Allergy Immunotherapy Sales by Type (2018-2023) & (K Units)
    Table 6. Global Allergy Immunotherapy Sales Market Share by Type (2018-2023)
    Table 7. Global Allergy Immunotherapy Revenue by Type (2018-2023) & ($ million)
    Table 8. Global Allergy Immunotherapy Revenue Market Share by Type (2018-2023)
    Table 9. Global Allergy Immunotherapy Sale Price by Type (2018-2023) & (USD/Unit)
    Table 10. Global Allergy Immunotherapy Sales by Application (2018-2023) & (K Units)
    Table 11. Global Allergy Immunotherapy Sales Market Share by Application (2018-2023)
    Table 12. Global Allergy Immunotherapy Revenue by Application (2018-2023)
    Table 13. Global Allergy Immunotherapy Revenue Market Share by Application (2018-2023)
    Table 14. Global Allergy Immunotherapy Sale Price by Application (2018-2023) & (USD/Unit)
    Table 15. Global Allergy Immunotherapy Sales by Company (2018-2023) & (K Units)
    Table 16. Global Allergy Immunotherapy Sales Market Share by Company (2018-2023)
    Table 17. Global Allergy Immunotherapy Revenue by Company (2018-2023) ($ Millions)
    Table 18. Global Allergy Immunotherapy Revenue Market Share by Company (2018-2023)
    Table 19. Global Allergy Immunotherapy Sale Price by Company (2018-2023) & (USD/Unit)
    Table 20. Key Manufacturers Allergy Immunotherapy Producing Area Distribution and Sales Area
    Table 21. Players Allergy Immunotherapy Products Offered
    Table 22. Allergy Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Allergy Immunotherapy Sales by Geographic Region (2018-2023) & (K Units)
    Table 26. Global Allergy Immunotherapy Sales Market Share Geographic Region (2018-2023)
    Table 27. Global Allergy Immunotherapy Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 28. Global Allergy Immunotherapy Revenue Market Share by Geographic Region (2018-2023)
    Table 29. Global Allergy Immunotherapy Sales by Country/Region (2018-2023) & (K Units)
    Table 30. Global Allergy Immunotherapy Sales Market Share by Country/Region (2018-2023)
    Table 31. Global Allergy Immunotherapy Revenue by Country/Region (2018-2023) & ($ millions)
    Table 32. Global Allergy Immunotherapy Revenue Market Share by Country/Region (2018-2023)
    Table 33. Americas Allergy Immunotherapy Sales by Country (2018-2023) & (K Units)
    Table 34. Americas Allergy Immunotherapy Sales Market Share by Country (2018-2023)
    Table 35. Americas Allergy Immunotherapy Revenue by Country (2018-2023) & ($ Millions)
    Table 36. Americas Allergy Immunotherapy Revenue Market Share by Country (2018-2023)
    Table 37. Americas Allergy Immunotherapy Sales by Type (2018-2023) & (K Units)
    Table 38. Americas Allergy Immunotherapy Sales by Application (2018-2023) & (K Units)
    Table 39. APAC Allergy Immunotherapy Sales by Region (2018-2023) & (K Units)
    Table 40. APAC Allergy Immunotherapy Sales Market Share by Region (2018-2023)
    Table 41. APAC Allergy Immunotherapy Revenue by Region (2018-2023) & ($ Millions)
    Table 42. APAC Allergy Immunotherapy Revenue Market Share by Region (2018-2023)
    Table 43. APAC Allergy Immunotherapy Sales by Type (2018-2023) & (K Units)
    Table 44. APAC Allergy Immunotherapy Sales by Application (2018-2023) & (K Units)
    Table 45. Europe Allergy Immunotherapy Sales by Country (2018-2023) & (K Units)
    Table 46. Europe Allergy Immunotherapy Sales Market Share by Country (2018-2023)
    Table 47. Europe Allergy Immunotherapy Revenue by Country (2018-2023) & ($ Millions)
    Table 48. Europe Allergy Immunotherapy Revenue Market Share by Country (2018-2023)
    Table 49. Europe Allergy Immunotherapy Sales by Type (2018-2023) & (K Units)
    Table 50. Europe Allergy Immunotherapy Sales by Application (2018-2023) & (K Units)
    Table 51. Middle East & Africa Allergy Immunotherapy Sales by Country (2018-2023) & (K Units)
    Table 52. Middle East & Africa Allergy Immunotherapy Sales Market Share by Country (2018-2023)
    Table 53. Middle East & Africa Allergy Immunotherapy Revenue by Country (2018-2023) & ($ Millions)
    Table 54. Middle East & Africa Allergy Immunotherapy Revenue Market Share by Country (2018-2023)
    Table 55. Middle East & Africa Allergy Immunotherapy Sales by Type (2018-2023) & (K Units)
    Table 56. Middle East & Africa Allergy Immunotherapy Sales by Application (2018-2023) & (K Units)
    Table 57. Key Market Drivers & Growth Opportunities of Allergy Immunotherapy
    Table 58. Key Market Challenges & Risks of Allergy Immunotherapy
    Table 59. Key Industry Trends of Allergy Immunotherapy
    Table 60. Allergy Immunotherapy Raw Material
    Table 61. Key Suppliers of Raw Materials
    Table 62. Allergy Immunotherapy Distributors List
    Table 63. Allergy Immunotherapy Customer List
    Table 64. Global Allergy Immunotherapy Sales Forecast by Region (2024-2029) & (K Units)
    Table 65. Global Allergy Immunotherapy Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 66. Americas Allergy Immunotherapy Sales Forecast by Country (2024-2029) & (K Units)
    Table 67. Americas Allergy Immunotherapy Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 68. APAC Allergy Immunotherapy Sales Forecast by Region (2024-2029) & (K Units)
    Table 69. APAC Allergy Immunotherapy Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 70. Europe Allergy Immunotherapy Sales Forecast by Country (2024-2029) & (K Units)
    Table 71. Europe Allergy Immunotherapy Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 72. Middle East & Africa Allergy Immunotherapy Sales Forecast by Country (2024-2029) & (K Units)
    Table 73. Middle East & Africa Allergy Immunotherapy Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 74. Global Allergy Immunotherapy Sales Forecast by Type (2024-2029) & (K Units)
    Table 75. Global Allergy Immunotherapy Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 76. Global Allergy Immunotherapy Sales Forecast by Application (2024-2029) & (K Units)
    Table 77. Global Allergy Immunotherapy Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 78. ALK-Abello Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
    Table 79. ALK-Abello Allergy Immunotherapy Product Portfolios and Specifications
    Table 80. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 81. ALK-Abello Main Business
    Table 82. ALK-Abello Latest Developments
    Table 83. Stallergenes Greer Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
    Table 84. Stallergenes Greer Allergy Immunotherapy Product Portfolios and Specifications
    Table 85. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 86. Stallergenes Greer Main Business
    Table 87. Stallergenes Greer Latest Developments
    Table 88. Merck Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
    Table 89. Merck Allergy Immunotherapy Product Portfolios and Specifications
    Table 90. Merck Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 91. Merck Main Business
    Table 92. Merck Latest Developments
    Table 93. Allergy Therapeutics Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
    Table 94. Allergy Therapeutics Allergy Immunotherapy Product Portfolios and Specifications
    Table 95. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 96. Allergy Therapeutics Main Business
    Table 97. Allergy Therapeutics Latest Developments
    Table 98. HAL Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
    Table 99. HAL Allergy Immunotherapy Product Portfolios and Specifications
    Table 100. HAL Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 101. HAL Main Business
    Table 102. HAL Latest Developments
    Table 103. Holister Stier Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
    Table 104. Holister Stier Allergy Immunotherapy Product Portfolios and Specifications
    Table 105. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 106. Holister Stier Main Business
    Table 107. Holister Stier Latest Developments
    Table 108. Leti Basic Information, Allergy Immunotherapy Manufacturing Base, Sales Area and Its Competitors
    Table 109. Leti Allergy Immunotherapy Product Portfolios and Specifications
    Table 110. Leti Allergy Immunotherapy Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 111. Leti Main Business
    Table 112. Leti Latest Developments
List of Figures
    Figure 1. Picture of Allergy Immunotherapy
    Figure 2. Allergy Immunotherapy Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Allergy Immunotherapy Sales Growth Rate 2018-2029 (K Units)
    Figure 7. Global Allergy Immunotherapy Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Allergy Immunotherapy Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Subcutaneous Immunotherapy
    Figure 10. Product Picture of Sublingual Immunotherapy
    Figure 11. Global Allergy Immunotherapy Sales Market Share by Type in 2022
    Figure 12. Global Allergy Immunotherapy Revenue Market Share by Type (2018-2023)
    Figure 13. Allergy Immunotherapy Consumed in Allergic Rhinitis
    Figure 14. Global Allergy Immunotherapy Market: Allergic Rhinitis (2018-2023) & (K Units)
    Figure 15. Allergy Immunotherapy Consumed in Allergic Asthma
    Figure 16. Global Allergy Immunotherapy Market: Allergic Asthma (2018-2023) & (K Units)
    Figure 17. Allergy Immunotherapy Consumed in Others
    Figure 18. Global Allergy Immunotherapy Market: Others (2018-2023) & (K Units)
    Figure 19. Global Allergy Immunotherapy Sales Market Share by Application (2022)
    Figure 20. Global Allergy Immunotherapy Revenue Market Share by Application in 2022
    Figure 21. Allergy Immunotherapy Sales Market by Company in 2022 (K Units)
    Figure 22. Global Allergy Immunotherapy Sales Market Share by Company in 2022
    Figure 23. Allergy Immunotherapy Revenue Market by Company in 2022 ($ Million)
    Figure 24. Global Allergy Immunotherapy Revenue Market Share by Company in 2022
    Figure 25. Global Allergy Immunotherapy Sales Market Share by Geographic Region (2018-2023)
    Figure 26. Global Allergy Immunotherapy Revenue Market Share by Geographic Region in 2022
    Figure 27. Americas Allergy Immunotherapy Sales 2018-2023 (K Units)
    Figure 28. Americas Allergy Immunotherapy Revenue 2018-2023 ($ Millions)
    Figure 29. APAC Allergy Immunotherapy Sales 2018-2023 (K Units)
    Figure 30. APAC Allergy Immunotherapy Revenue 2018-2023 ($ Millions)
    Figure 31. Europe Allergy Immunotherapy Sales 2018-2023 (K Units)
    Figure 32. Europe Allergy Immunotherapy Revenue 2018-2023 ($ Millions)
    Figure 33. Middle East & Africa Allergy Immunotherapy Sales 2018-2023 (K Units)
    Figure 34. Middle East & Africa Allergy Immunotherapy Revenue 2018-2023 ($ Millions)
    Figure 35. Americas Allergy Immunotherapy Sales Market Share by Country in 2022
    Figure 36. Americas Allergy Immunotherapy Revenue Market Share by Country in 2022
    Figure 37. Americas Allergy Immunotherapy Sales Market Share by Type (2018-2023)
    Figure 38. Americas Allergy Immunotherapy Sales Market Share by Application (2018-2023)
    Figure 39. United States Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Canada Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Mexico Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 42. Brazil Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 43. APAC Allergy Immunotherapy Sales Market Share by Region in 2022
    Figure 44. APAC Allergy Immunotherapy Revenue Market Share by Regions in 2022
    Figure 45. APAC Allergy Immunotherapy Sales Market Share by Type (2018-2023)
    Figure 46. APAC Allergy Immunotherapy Sales Market Share by Application (2018-2023)
    Figure 47. China Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 48. Japan Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 49. South Korea Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 50. Southeast Asia Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 51. India Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 52. Australia Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 53. China Taiwan Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 54. Europe Allergy Immunotherapy Sales Market Share by Country in 2022
    Figure 55. Europe Allergy Immunotherapy Revenue Market Share by Country in 2022
    Figure 56. Europe Allergy Immunotherapy Sales Market Share by Type (2018-2023)
    Figure 57. Europe Allergy Immunotherapy Sales Market Share by Application (2018-2023)
    Figure 58. Germany Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 59. France Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 60. UK Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Italy Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Russia Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 63. Middle East & Africa Allergy Immunotherapy Sales Market Share by Country in 2022
    Figure 64. Middle East & Africa Allergy Immunotherapy Revenue Market Share by Country in 2022
    Figure 65. Middle East & Africa Allergy Immunotherapy Sales Market Share by Type (2018-2023)
    Figure 66. Middle East & Africa Allergy Immunotherapy Sales Market Share by Application (2018-2023)
    Figure 67. Egypt Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 68. South Africa Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Israel Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 70. Turkey Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 71. GCC Country Allergy Immunotherapy Revenue Growth 2018-2023 ($ Millions)
    Figure 72. Manufacturing Cost Structure Analysis of Allergy Immunotherapy in 2022
    Figure 73. Manufacturing Process Analysis of Allergy Immunotherapy
    Figure 74. Industry Chain Structure of Allergy Immunotherapy
    Figure 75. Channels of Distribution
    Figure 76. Global Allergy Immunotherapy Sales Market Forecast by Region (2024-2029)
    Figure 77. Global Allergy Immunotherapy Revenue Market Share Forecast by Region (2024-2029)
    Figure 78. Global Allergy Immunotherapy Sales Market Share Forecast by Type (2024-2029)
    Figure 79. Global Allergy Immunotherapy Revenue Market Share Forecast by Type (2024-2029)
    Figure 80. Global Allergy Immunotherapy Sales Market Share Forecast by Application (2024-2029)
    Figure 81. Global Allergy Immunotherapy Revenue Market Share Forecast by Application (2024-2029)

ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape